Global Cell-free DNA Mutation Diagnostics Market Growth (Status and Outlook) 2026-2032
The global Cell-free DNA Mutation Diagnostics market size is predicted to grow from US$ 9027 million in 2025 to US$ 24400 million in 2032; it is expected to grow at a CAGR of 15.6% from 2026 to 2032.
Cell-free DNA Mutation Diagnostics is a cutting-edge diagnostic technique that analyzes cell-free DNA (cfDNA) in bodily fluids (typically blood or urine) to detect genetic mutations associated with diseases, especially cancer. cfDNA refers to DNA fragments that are released into the bloodstream when cells die or break down. This method provides a non-invasive alternative to traditional biopsy procedures for detecting genetic mutations, enabling early disease detection, monitoring, and personalized treatment planning.
United States market for Cell-free DNA Mutation Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell-free DNA Mutation Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell-free DNA Mutation Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell-free DNA Mutation Diagnostics players cover Illumina, Natera, Guardant, Freenome Holdings, GRAIL, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Cell-free DNA Mutation Diagnostics Industry Forecast? looks at past sales and reviews total world Cell-free DNA Mutation Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell-free DNA Mutation Diagnostics sales for 2026 through 2032. With Cell-free DNA Mutation Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell-free DNA Mutation Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Cell-free DNA Mutation Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell-free DNA Mutation Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cell-free DNA Mutation Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell-free DNA Mutation Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell-free DNA Mutation Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell-free DNA Mutation Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cell-free DNA Mutation Diagnostics is a cutting-edge diagnostic technique that analyzes cell-free DNA (cfDNA) in bodily fluids (typically blood or urine) to detect genetic mutations associated with diseases, especially cancer. cfDNA refers to DNA fragments that are released into the bloodstream when cells die or break down. This method provides a non-invasive alternative to traditional biopsy procedures for detecting genetic mutations, enabling early disease detection, monitoring, and personalized treatment planning.
United States market for Cell-free DNA Mutation Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell-free DNA Mutation Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell-free DNA Mutation Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell-free DNA Mutation Diagnostics players cover Illumina, Natera, Guardant, Freenome Holdings, GRAIL, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Cell-free DNA Mutation Diagnostics Industry Forecast? looks at past sales and reviews total world Cell-free DNA Mutation Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell-free DNA Mutation Diagnostics sales for 2026 through 2032. With Cell-free DNA Mutation Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell-free DNA Mutation Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Cell-free DNA Mutation Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell-free DNA Mutation Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cell-free DNA Mutation Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell-free DNA Mutation Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell-free DNA Mutation Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell-free DNA Mutation Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Kits
- Instruments
- Services
- Hoispital
- Clinic
- Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Illumina
- Natera
- Guardant
- Freenome Holdings
- GRAIL
- Exact Sciences Corporation
- Foundation Medicine
- Biocept
- Thermo Fisher Scientific
- Roche Diagnostics
- Agilent Technologies
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Myriad Genetics
- BillionToOne
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell-free DNA Mutation Diagnostics Market Size (2021-2032)
2.1.2 Cell-free DNA Mutation Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell-free DNA Mutation Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Cell-free DNA Mutation Diagnostics Segment by Type
2.2.1 Kits
2.2.2 Instruments
2.2.3 Services
2.2.4 Cell-free DNA Mutation Diagnostics Market Size by Type
2.2.4.1 Cell-free DNA Mutation Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Cell-free DNA Mutation Diagnostics Segment by Application
2.3.1 Hoispital
2.3.2 Clinic
2.3.3 Laboratories
2.3.4 Others
2.3.5 Cell-free DNA Mutation Diagnostics Market Size by Application
2.3.5.1 Cell-free DNA Mutation Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
3 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Cell-free DNA Mutation Diagnostics Market Size Market Share by Player
3.1.1 Global Cell-free DNA Mutation Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Cell-free DNA Mutation Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL-FREE DNA MUTATION DIAGNOSTICS BY REGION
4.1 Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026)
4.2 Global Cell-free DNA Mutation Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell-free DNA Mutation Diagnostics Market Size Growth (2021-2026)
4.4 APAC Cell-free DNA Mutation Diagnostics Market Size Growth (2021-2026)
4.5 Europe Cell-free DNA Mutation Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell-free DNA Mutation Diagnostics Market Size by Country (2021-2026)
5.2 Americas Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026)
5.3 Americas Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026)
6.2 APAC Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026)
6.3 APAC Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2021-2026)
7.2 Europe Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026)
7.3 Europe Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell-free DNA Mutation Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL-FREE DNA MUTATION DIAGNOSTICS MARKET FORECAST
10.1 Global Cell-free DNA Mutation Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Cell-free DNA Mutation Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Cell-free DNA Mutation Diagnostics Forecast
10.1.3 APAC Cell-free DNA Mutation Diagnostics Forecast
10.1.4 Europe Cell-free DNA Mutation Diagnostics Forecast
10.1.5 Middle East & Africa Cell-free DNA Mutation Diagnostics Forecast
10.2 Americas Cell-free DNA Mutation Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Cell-free DNA Mutation Diagnostics Forecast
10.2.2 Canada Market Cell-free DNA Mutation Diagnostics Forecast
10.2.3 Mexico Market Cell-free DNA Mutation Diagnostics Forecast
10.2.4 Brazil Market Cell-free DNA Mutation Diagnostics Forecast
10.3 APAC Cell-free DNA Mutation Diagnostics Forecast by Region (2027-2032)
10.3.1 China Cell-free DNA Mutation Diagnostics Market Forecast
10.3.2 Japan Market Cell-free DNA Mutation Diagnostics Forecast
10.3.3 Korea Market Cell-free DNA Mutation Diagnostics Forecast
10.3.4 Southeast Asia Market Cell-free DNA Mutation Diagnostics Forecast
10.3.5 India Market Cell-free DNA Mutation Diagnostics Forecast
10.3.6 Australia Market Cell-free DNA Mutation Diagnostics Forecast
10.4 Europe Cell-free DNA Mutation Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Cell-free DNA Mutation Diagnostics Forecast
10.4.2 France Market Cell-free DNA Mutation Diagnostics Forecast
10.4.3 UK Market Cell-free DNA Mutation Diagnostics Forecast
10.4.4 Italy Market Cell-free DNA Mutation Diagnostics Forecast
10.4.5 Russia Market Cell-free DNA Mutation Diagnostics Forecast
10.5 Middle East & Africa Cell-free DNA Mutation Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell-free DNA Mutation Diagnostics Forecast
10.5.2 South Africa Market Cell-free DNA Mutation Diagnostics Forecast
10.5.3 Israel Market Cell-free DNA Mutation Diagnostics Forecast
10.5.4 Turkey Market Cell-free DNA Mutation Diagnostics Forecast
10.6 Global Cell-free DNA Mutation Diagnostics Forecast by Type (2027-2032)
10.7 Global Cell-free DNA Mutation Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell-free DNA Mutation Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Cell-free DNA Mutation Diagnostics Product Offered
11.1.3 Illumina Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Natera
11.2.1 Natera Company Information
11.2.2 Natera Cell-free DNA Mutation Diagnostics Product Offered
11.2.3 Natera Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Natera Main Business Overview
11.2.5 Natera Latest Developments
11.3 Guardant
11.3.1 Guardant Company Information
11.3.2 Guardant Cell-free DNA Mutation Diagnostics Product Offered
11.3.3 Guardant Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Guardant Main Business Overview
11.3.5 Guardant Latest Developments
11.4 Freenome Holdings
11.4.1 Freenome Holdings Company Information
11.4.2 Freenome Holdings Cell-free DNA Mutation Diagnostics Product Offered
11.4.3 Freenome Holdings Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Freenome Holdings Main Business Overview
11.4.5 Freenome Holdings Latest Developments
11.5 GRAIL
11.5.1 GRAIL Company Information
11.5.2 GRAIL Cell-free DNA Mutation Diagnostics Product Offered
11.5.3 GRAIL Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 GRAIL Main Business Overview
11.5.5 GRAIL Latest Developments
11.6 Exact Sciences Corporation
11.6.1 Exact Sciences Corporation Company Information
11.6.2 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Offered
11.6.3 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Exact Sciences Corporation Main Business Overview
11.6.5 Exact Sciences Corporation Latest Developments
11.7 Foundation Medicine
11.7.1 Foundation Medicine Company Information
11.7.2 Foundation Medicine Cell-free DNA Mutation Diagnostics Product Offered
11.7.3 Foundation Medicine Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Foundation Medicine Main Business Overview
11.7.5 Foundation Medicine Latest Developments
11.8 Biocept
11.8.1 Biocept Company Information
11.8.2 Biocept Cell-free DNA Mutation Diagnostics Product Offered
11.8.3 Biocept Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Biocept Main Business Overview
11.8.5 Biocept Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Offered
11.9.3 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
11.10 Roche Diagnostics
11.10.1 Roche Diagnostics Company Information
11.10.2 Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Offered
11.10.3 Roche Diagnostics Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Roche Diagnostics Main Business Overview
11.10.5 Roche Diagnostics Latest Developments
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Information
11.11.2 Agilent Technologies Cell-free DNA Mutation Diagnostics Product Offered
11.11.3 Agilent Technologies Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Agilent Technologies Main Business Overview
11.11.5 Agilent Technologies Latest Developments
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Information
11.12.2 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Offered
11.12.3 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Quest Diagnostics Incorporated Main Business Overview
11.12.5 Quest Diagnostics Incorporated Latest Developments
11.13 Laboratory Corporation of America Holdings
11.13.1 Laboratory Corporation of America Holdings Company Information
11.13.2 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Offered
11.13.3 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Laboratory Corporation of America Holdings Main Business Overview
11.13.5 Laboratory Corporation of America Holdings Latest Developments
11.14 Myriad Genetics
11.14.1 Myriad Genetics Company Information
11.14.2 Myriad Genetics Cell-free DNA Mutation Diagnostics Product Offered
11.14.3 Myriad Genetics Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Myriad Genetics Main Business Overview
11.14.5 Myriad Genetics Latest Developments
11.15 BillionToOne
11.15.1 BillionToOne Company Information
11.15.2 BillionToOne Cell-free DNA Mutation Diagnostics Product Offered
11.15.3 BillionToOne Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 BillionToOne Main Business Overview
11.15.5 BillionToOne Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell-free DNA Mutation Diagnostics Market Size (2021-2032)
2.1.2 Cell-free DNA Mutation Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell-free DNA Mutation Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Cell-free DNA Mutation Diagnostics Segment by Type
2.2.1 Kits
2.2.2 Instruments
2.2.3 Services
2.2.4 Cell-free DNA Mutation Diagnostics Market Size by Type
2.2.4.1 Cell-free DNA Mutation Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Cell-free DNA Mutation Diagnostics Segment by Application
2.3.1 Hoispital
2.3.2 Clinic
2.3.3 Laboratories
2.3.4 Others
2.3.5 Cell-free DNA Mutation Diagnostics Market Size by Application
2.3.5.1 Cell-free DNA Mutation Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
3 CELL-FREE DNA MUTATION DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Cell-free DNA Mutation Diagnostics Market Size Market Share by Player
3.1.1 Global Cell-free DNA Mutation Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Cell-free DNA Mutation Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL-FREE DNA MUTATION DIAGNOSTICS BY REGION
4.1 Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026)
4.2 Global Cell-free DNA Mutation Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell-free DNA Mutation Diagnostics Market Size Growth (2021-2026)
4.4 APAC Cell-free DNA Mutation Diagnostics Market Size Growth (2021-2026)
4.5 Europe Cell-free DNA Mutation Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell-free DNA Mutation Diagnostics Market Size by Country (2021-2026)
5.2 Americas Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026)
5.3 Americas Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026)
6.2 APAC Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026)
6.3 APAC Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2021-2026)
7.2 Europe Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026)
7.3 Europe Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell-free DNA Mutation Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL-FREE DNA MUTATION DIAGNOSTICS MARKET FORECAST
10.1 Global Cell-free DNA Mutation Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Cell-free DNA Mutation Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Cell-free DNA Mutation Diagnostics Forecast
10.1.3 APAC Cell-free DNA Mutation Diagnostics Forecast
10.1.4 Europe Cell-free DNA Mutation Diagnostics Forecast
10.1.5 Middle East & Africa Cell-free DNA Mutation Diagnostics Forecast
10.2 Americas Cell-free DNA Mutation Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Cell-free DNA Mutation Diagnostics Forecast
10.2.2 Canada Market Cell-free DNA Mutation Diagnostics Forecast
10.2.3 Mexico Market Cell-free DNA Mutation Diagnostics Forecast
10.2.4 Brazil Market Cell-free DNA Mutation Diagnostics Forecast
10.3 APAC Cell-free DNA Mutation Diagnostics Forecast by Region (2027-2032)
10.3.1 China Cell-free DNA Mutation Diagnostics Market Forecast
10.3.2 Japan Market Cell-free DNA Mutation Diagnostics Forecast
10.3.3 Korea Market Cell-free DNA Mutation Diagnostics Forecast
10.3.4 Southeast Asia Market Cell-free DNA Mutation Diagnostics Forecast
10.3.5 India Market Cell-free DNA Mutation Diagnostics Forecast
10.3.6 Australia Market Cell-free DNA Mutation Diagnostics Forecast
10.4 Europe Cell-free DNA Mutation Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Cell-free DNA Mutation Diagnostics Forecast
10.4.2 France Market Cell-free DNA Mutation Diagnostics Forecast
10.4.3 UK Market Cell-free DNA Mutation Diagnostics Forecast
10.4.4 Italy Market Cell-free DNA Mutation Diagnostics Forecast
10.4.5 Russia Market Cell-free DNA Mutation Diagnostics Forecast
10.5 Middle East & Africa Cell-free DNA Mutation Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell-free DNA Mutation Diagnostics Forecast
10.5.2 South Africa Market Cell-free DNA Mutation Diagnostics Forecast
10.5.3 Israel Market Cell-free DNA Mutation Diagnostics Forecast
10.5.4 Turkey Market Cell-free DNA Mutation Diagnostics Forecast
10.6 Global Cell-free DNA Mutation Diagnostics Forecast by Type (2027-2032)
10.7 Global Cell-free DNA Mutation Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell-free DNA Mutation Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Cell-free DNA Mutation Diagnostics Product Offered
11.1.3 Illumina Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Natera
11.2.1 Natera Company Information
11.2.2 Natera Cell-free DNA Mutation Diagnostics Product Offered
11.2.3 Natera Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Natera Main Business Overview
11.2.5 Natera Latest Developments
11.3 Guardant
11.3.1 Guardant Company Information
11.3.2 Guardant Cell-free DNA Mutation Diagnostics Product Offered
11.3.3 Guardant Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Guardant Main Business Overview
11.3.5 Guardant Latest Developments
11.4 Freenome Holdings
11.4.1 Freenome Holdings Company Information
11.4.2 Freenome Holdings Cell-free DNA Mutation Diagnostics Product Offered
11.4.3 Freenome Holdings Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Freenome Holdings Main Business Overview
11.4.5 Freenome Holdings Latest Developments
11.5 GRAIL
11.5.1 GRAIL Company Information
11.5.2 GRAIL Cell-free DNA Mutation Diagnostics Product Offered
11.5.3 GRAIL Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 GRAIL Main Business Overview
11.5.5 GRAIL Latest Developments
11.6 Exact Sciences Corporation
11.6.1 Exact Sciences Corporation Company Information
11.6.2 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Offered
11.6.3 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Exact Sciences Corporation Main Business Overview
11.6.5 Exact Sciences Corporation Latest Developments
11.7 Foundation Medicine
11.7.1 Foundation Medicine Company Information
11.7.2 Foundation Medicine Cell-free DNA Mutation Diagnostics Product Offered
11.7.3 Foundation Medicine Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Foundation Medicine Main Business Overview
11.7.5 Foundation Medicine Latest Developments
11.8 Biocept
11.8.1 Biocept Company Information
11.8.2 Biocept Cell-free DNA Mutation Diagnostics Product Offered
11.8.3 Biocept Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Biocept Main Business Overview
11.8.5 Biocept Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Offered
11.9.3 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
11.10 Roche Diagnostics
11.10.1 Roche Diagnostics Company Information
11.10.2 Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Offered
11.10.3 Roche Diagnostics Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Roche Diagnostics Main Business Overview
11.10.5 Roche Diagnostics Latest Developments
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Information
11.11.2 Agilent Technologies Cell-free DNA Mutation Diagnostics Product Offered
11.11.3 Agilent Technologies Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Agilent Technologies Main Business Overview
11.11.5 Agilent Technologies Latest Developments
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Information
11.12.2 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Offered
11.12.3 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Quest Diagnostics Incorporated Main Business Overview
11.12.5 Quest Diagnostics Incorporated Latest Developments
11.13 Laboratory Corporation of America Holdings
11.13.1 Laboratory Corporation of America Holdings Company Information
11.13.2 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Offered
11.13.3 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Laboratory Corporation of America Holdings Main Business Overview
11.13.5 Laboratory Corporation of America Holdings Latest Developments
11.14 Myriad Genetics
11.14.1 Myriad Genetics Company Information
11.14.2 Myriad Genetics Cell-free DNA Mutation Diagnostics Product Offered
11.14.3 Myriad Genetics Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Myriad Genetics Main Business Overview
11.14.5 Myriad Genetics Latest Developments
11.15 BillionToOne
11.15.1 BillionToOne Company Information
11.15.2 BillionToOne Cell-free DNA Mutation Diagnostics Product Offered
11.15.3 BillionToOne Cell-free DNA Mutation Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 BillionToOne Main Business Overview
11.15.5 BillionToOne Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell-free DNA Mutation Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell-free DNA Mutation Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Kits
Table 4. Major Players of Instruments
Table 5. Major Players of Services
Table 6. Cell-free DNA Mutation Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Table 9. Cell-free DNA Mutation Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Table 12. Global Cell-free DNA Mutation Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Player (2021-2026)
Table 14. Cell-free DNA Mutation Diagnostics Key Players Head office and Products Offered
Table 15. Cell-free DNA Mutation Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Region (2021-2026)
Table 20. Global Cell-free DNA Mutation Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Cell-free DNA Mutation Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Cell-free DNA Mutation Diagnostics Market Size Market Share by Country (2021-2026)
Table 24. Americas Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Table 26. Americas Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Table 28. APAC Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Cell-free DNA Mutation Diagnostics Market Size Market Share by Region (2021-2026)
Table 30. APAC Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Cell-free DNA Mutation Diagnostics Market Size Market Share by Country (2021-2026)
Table 34. Europe Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cell-free DNA Mutation Diagnostics
Table 40. Key Market Challenges & Risks of Cell-free DNA Mutation Diagnostics
Table 41. Key Industry Trends of Cell-free DNA Mutation Diagnostics
Table 42. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Cell-free DNA Mutation Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Illumina Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 47. Illumina Cell-free DNA Mutation Diagnostics Product Offered
Table 48. Illumina Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Illumina Main Business
Table 50. Illumina Latest Developments
Table 51. Natera Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 52. Natera Cell-free DNA Mutation Diagnostics Product Offered
Table 53. Natera Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Natera Main Business
Table 55. Natera Latest Developments
Table 56. Guardant Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 57. Guardant Cell-free DNA Mutation Diagnostics Product Offered
Table 58. Guardant Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Guardant Main Business
Table 60. Guardant Latest Developments
Table 61. Freenome Holdings Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 62. Freenome Holdings Cell-free DNA Mutation Diagnostics Product Offered
Table 63. Freenome Holdings Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Freenome Holdings Main Business
Table 65. Freenome Holdings Latest Developments
Table 66. GRAIL Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 67. GRAIL Cell-free DNA Mutation Diagnostics Product Offered
Table 68. GRAIL Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. GRAIL Main Business
Table 70. GRAIL Latest Developments
Table 71. Exact Sciences Corporation Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 72. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Offered
Table 73. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Exact Sciences Corporation Main Business
Table 75. Exact Sciences Corporation Latest Developments
Table 76. Foundation Medicine Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 77. Foundation Medicine Cell-free DNA Mutation Diagnostics Product Offered
Table 78. Foundation Medicine Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Foundation Medicine Main Business
Table 80. Foundation Medicine Latest Developments
Table 81. Biocept Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 82. Biocept Cell-free DNA Mutation Diagnostics Product Offered
Table 83. Biocept Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Biocept Main Business
Table 85. Biocept Latest Developments
Table 86. Thermo Fisher Scientific Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 87. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Offered
Table 88. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Thermo Fisher Scientific Main Business
Table 90. Thermo Fisher Scientific Latest Developments
Table 91. Roche Diagnostics Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 92. Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Offered
Table 93. Roche Diagnostics Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Roche Diagnostics Main Business
Table 95. Roche Diagnostics Latest Developments
Table 96. Agilent Technologies Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 97. Agilent Technologies Cell-free DNA Mutation Diagnostics Product Offered
Table 98. Agilent Technologies Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Agilent Technologies Main Business
Table 100. Agilent Technologies Latest Developments
Table 101. Quest Diagnostics Incorporated Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 102. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Offered
Table 103. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Quest Diagnostics Incorporated Main Business
Table 105. Quest Diagnostics Incorporated Latest Developments
Table 106. Laboratory Corporation of America Holdings Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 107. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Offered
Table 108. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Laboratory Corporation of America Holdings Main Business
Table 110. Laboratory Corporation of America Holdings Latest Developments
Table 111. Myriad Genetics Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 112. Myriad Genetics Cell-free DNA Mutation Diagnostics Product Offered
Table 113. Myriad Genetics Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Myriad Genetics Main Business
Table 115. Myriad Genetics Latest Developments
Table 116. BillionToOne Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 117. BillionToOne Cell-free DNA Mutation Diagnostics Product Offered
Table 118. BillionToOne Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. BillionToOne Main Business
Table 120. BillionToOne Latest Developments
Table 1. Cell-free DNA Mutation Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell-free DNA Mutation Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Kits
Table 4. Major Players of Instruments
Table 5. Major Players of Services
Table 6. Cell-free DNA Mutation Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Table 9. Cell-free DNA Mutation Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Table 12. Global Cell-free DNA Mutation Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Player (2021-2026)
Table 14. Cell-free DNA Mutation Diagnostics Key Players Head office and Products Offered
Table 15. Cell-free DNA Mutation Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Region (2021-2026)
Table 20. Global Cell-free DNA Mutation Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Cell-free DNA Mutation Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Cell-free DNA Mutation Diagnostics Market Size Market Share by Country (2021-2026)
Table 24. Americas Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Table 26. Americas Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Table 28. APAC Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Cell-free DNA Mutation Diagnostics Market Size Market Share by Region (2021-2026)
Table 30. APAC Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Cell-free DNA Mutation Diagnostics Market Size Market Share by Country (2021-2026)
Table 34. Europe Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cell-free DNA Mutation Diagnostics
Table 40. Key Market Challenges & Risks of Cell-free DNA Mutation Diagnostics
Table 41. Key Industry Trends of Cell-free DNA Mutation Diagnostics
Table 42. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Cell-free DNA Mutation Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Cell-free DNA Mutation Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Illumina Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 47. Illumina Cell-free DNA Mutation Diagnostics Product Offered
Table 48. Illumina Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Illumina Main Business
Table 50. Illumina Latest Developments
Table 51. Natera Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 52. Natera Cell-free DNA Mutation Diagnostics Product Offered
Table 53. Natera Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Natera Main Business
Table 55. Natera Latest Developments
Table 56. Guardant Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 57. Guardant Cell-free DNA Mutation Diagnostics Product Offered
Table 58. Guardant Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Guardant Main Business
Table 60. Guardant Latest Developments
Table 61. Freenome Holdings Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 62. Freenome Holdings Cell-free DNA Mutation Diagnostics Product Offered
Table 63. Freenome Holdings Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Freenome Holdings Main Business
Table 65. Freenome Holdings Latest Developments
Table 66. GRAIL Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 67. GRAIL Cell-free DNA Mutation Diagnostics Product Offered
Table 68. GRAIL Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. GRAIL Main Business
Table 70. GRAIL Latest Developments
Table 71. Exact Sciences Corporation Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 72. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product Offered
Table 73. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Exact Sciences Corporation Main Business
Table 75. Exact Sciences Corporation Latest Developments
Table 76. Foundation Medicine Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 77. Foundation Medicine Cell-free DNA Mutation Diagnostics Product Offered
Table 78. Foundation Medicine Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Foundation Medicine Main Business
Table 80. Foundation Medicine Latest Developments
Table 81. Biocept Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 82. Biocept Cell-free DNA Mutation Diagnostics Product Offered
Table 83. Biocept Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Biocept Main Business
Table 85. Biocept Latest Developments
Table 86. Thermo Fisher Scientific Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 87. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product Offered
Table 88. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Thermo Fisher Scientific Main Business
Table 90. Thermo Fisher Scientific Latest Developments
Table 91. Roche Diagnostics Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 92. Roche Diagnostics Cell-free DNA Mutation Diagnostics Product Offered
Table 93. Roche Diagnostics Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Roche Diagnostics Main Business
Table 95. Roche Diagnostics Latest Developments
Table 96. Agilent Technologies Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 97. Agilent Technologies Cell-free DNA Mutation Diagnostics Product Offered
Table 98. Agilent Technologies Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Agilent Technologies Main Business
Table 100. Agilent Technologies Latest Developments
Table 101. Quest Diagnostics Incorporated Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 102. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product Offered
Table 103. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Quest Diagnostics Incorporated Main Business
Table 105. Quest Diagnostics Incorporated Latest Developments
Table 106. Laboratory Corporation of America Holdings Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 107. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product Offered
Table 108. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Laboratory Corporation of America Holdings Main Business
Table 110. Laboratory Corporation of America Holdings Latest Developments
Table 111. Myriad Genetics Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 112. Myriad Genetics Cell-free DNA Mutation Diagnostics Product Offered
Table 113. Myriad Genetics Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Myriad Genetics Main Business
Table 115. Myriad Genetics Latest Developments
Table 116. BillionToOne Details, Company Type, Cell-free DNA Mutation Diagnostics Area Served and Its Competitors
Table 117. BillionToOne Cell-free DNA Mutation Diagnostics Product Offered
Table 118. BillionToOne Cell-free DNA Mutation Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. BillionToOne Main Business
Table 120. BillionToOne Latest Developments
LIST OF FIGURES
Figure 1. Cell-free DNA Mutation Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell-free DNA Mutation Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell-free DNA Mutation Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell-free DNA Mutation Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Cell-free DNA Mutation Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Type in 2025
Figure 10. Cell-free DNA Mutation Diagnostics in Hoispital
Figure 11. Global Cell-free DNA Mutation Diagnostics Market: Hoispital (2021-2026) & ($ millions)
Figure 12. Cell-free DNA Mutation Diagnostics in Clinic
Figure 13. Global Cell-free DNA Mutation Diagnostics Market: Clinic (2021-2026) & ($ millions)
Figure 14. Cell-free DNA Mutation Diagnostics in Laboratories
Figure 15. Global Cell-free DNA Mutation Diagnostics Market: Laboratories (2021-2026) & ($ millions)
Figure 16. Cell-free DNA Mutation Diagnostics in Others
Figure 17. Global Cell-free DNA Mutation Diagnostics Market: Others (2021-2026) & ($ millions)
Figure 18. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Application in 2025
Figure 19. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Player in 2025
Figure 20. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cell-free DNA Mutation Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. APAC Cell-free DNA Mutation Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Europe Cell-free DNA Mutation Diagnostics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size 2021-2026 ($ millions)
Figure 25. Americas Cell-free DNA Mutation Diagnostics Value Market Share by Country in 2025
Figure 26. United States Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cell-free DNA Mutation Diagnostics Market Size Market Share by Region in 2025
Figure 31. APAC Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Figure 33. China Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cell-free DNA Mutation Diagnostics Market Size Market Share by Country in 2025
Figure 40. Europe Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. APAC Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. Europe Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. United States Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Canada Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. China Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Japan Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. Korea Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. India Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. Australia Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. Germany Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. France Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. UK Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Italy Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. Russia Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Israel Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 78. Global Cell-free DNA Mutation Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cell-free DNA Mutation Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 1. Cell-free DNA Mutation Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell-free DNA Mutation Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell-free DNA Mutation Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell-free DNA Mutation Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Cell-free DNA Mutation Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Type in 2025
Figure 10. Cell-free DNA Mutation Diagnostics in Hoispital
Figure 11. Global Cell-free DNA Mutation Diagnostics Market: Hoispital (2021-2026) & ($ millions)
Figure 12. Cell-free DNA Mutation Diagnostics in Clinic
Figure 13. Global Cell-free DNA Mutation Diagnostics Market: Clinic (2021-2026) & ($ millions)
Figure 14. Cell-free DNA Mutation Diagnostics in Laboratories
Figure 15. Global Cell-free DNA Mutation Diagnostics Market: Laboratories (2021-2026) & ($ millions)
Figure 16. Cell-free DNA Mutation Diagnostics in Others
Figure 17. Global Cell-free DNA Mutation Diagnostics Market: Others (2021-2026) & ($ millions)
Figure 18. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Application in 2025
Figure 19. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Player in 2025
Figure 20. Global Cell-free DNA Mutation Diagnostics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Cell-free DNA Mutation Diagnostics Market Size 2021-2026 ($ millions)
Figure 22. APAC Cell-free DNA Mutation Diagnostics Market Size 2021-2026 ($ millions)
Figure 23. Europe Cell-free DNA Mutation Diagnostics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size 2021-2026 ($ millions)
Figure 25. Americas Cell-free DNA Mutation Diagnostics Value Market Share by Country in 2025
Figure 26. United States Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Cell-free DNA Mutation Diagnostics Market Size Market Share by Region in 2025
Figure 31. APAC Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Figure 33. China Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Cell-free DNA Mutation Diagnostics Market Size Market Share by Country in 2025
Figure 40. Europe Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Cell-free DNA Mutation Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 56. APAC Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 57. Europe Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 59. United States Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. Canada Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. China Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Japan Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. Korea Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. India Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. Australia Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. Germany Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. France Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. UK Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Italy Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. Russia Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Israel Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
Figure 78. Global Cell-free DNA Mutation Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Cell-free DNA Mutation Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Cell-free DNA Mutation Diagnostics Market Size 2027-2032 ($ millions)
